Copeptin is measured as an alternative to vasopressin, which plays a detrimental role in autosomal dominant polycystic kidney disease (ADPKD), and apelin regulates angiogenesis and stimulates endothelial cell growth and migration [40,41]. The gene discussed is APLN; the disease is autosomal dominant polycystic kidney disease.